|
Originally published In Press as doi:10.1074/jbc.M707692200 on May 30, 2008
J. Biol. Chem., Vol. 283, Issue 38, 25900-25912, September 19, 2008
Interleukin (IL) 1β Induction of IL-6 Is Mediated by a Novel Phosphatidylinositol 3-Kinase-dependent AKT/I B Kinase Pathway Targeting Activator Protein-1*
Catherine M. Cahill1 and
Jack T. Rogers
From the
Neurochemistry Laboratory, Department of Psychiatry-Neuroscience and Genetics and Aging Research Unit, Massachusetts General Hospital (East), Charlestown, Massachusetts 02129
Here we describe a novel role for the phosphatidylinositol 3-kinase/AKT pathway in mediating induction of interleukin-6 (IL-6) in response to IL-1. Pharmacological inhibition of phosphatidylinositol 3-kinase (PI3K) inhibited IL-6 mRNA and protein production. Overexpression of either dominant-negative AKT or I B kinase mutant, IKK T23A, containing a mutation in a functional AKT phosphorylation site, shown previously to be important for NF B activation, completely abrogated IL-6 promoter activation in response to IL-1. However, mutation of the consensus NF B site on the IL-6 promoter did not abrogate promoter activation by IL-1 in contrast to the AP-1 site mutation. IL-1 induces phosphorylation of IKK on the NF B inducing kinase (NIK) phosphorylation sites Ser176/Ser180 and on the Thr23 site, and although phosphorylation of IKK T23 is inhibited both by LY294002 and wortmannin, phosphorylation of Ser176/Ser180 is not. Neither inhibition of PI 3-kinase/AKT nor IKK T23A overexpression affected I B degradation in response to IL-1. Only partial inhibition by dominant-negative AKT and no inhibitory effect of IKK T23A was observed on an IL-6 promoter-specific NF B site in contrast to significant inhibitory effects on the AP-1 site. Taken together, we have discovered a novel PI 3-kinase/AKT-dependent pathway in response to IL-1, encompassing PI 3-kinase/AKT/IKK T23 upstream of AP-1. This novel pathway is a parallel pathway to the PI 3-kinase/AKT upstream of NF B and both are involved in IL-6 gene transcription in response to IL-1.
Received for publication, September 13, 2007
, and in revised form, April 28, 2008.
* This work was supported, in whole or in part, by National Institutes of Health Grant R01 AG20181. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom correspondence should be addressed: CNY 149, Rm. 2510, MA General Hospital, 13th St., Charlestown, MA 02129. Tel.: 617-775-5524; Fax: 617-726-4078; E-mail: ccahill{at}rics.bwh.harvard.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Papi, M. Contoli, P. Gasparini, L. Bristot, M. R. Edwards, M. Chicca, M. Leis, A. Ciaccia, G. Caramori, S. L. Johnston, et al.
Role of Xanthine Oxidase Activation and Reduced Glutathione Depletion in Rhinovirus Induction of Inflammation in Respiratory Epithelial Cells
J. Biol. Chem.,
October 17, 2008;
283(42):
28595 - 28606.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|